Sholeh Bazrafshan, MD, MS (@sholehbk) 's Twitter Profile
Sholeh Bazrafshan, MD, MS

@sholehbk

PGY-3 (AP/CP) #Pathology Resident at University of Cincinnati @UCincyPath

ID: 815057445072621568

calendar_today31-12-2016 04:50:12

203 Tweet

178 Followers

316 Following

Jay Hwang (@path4people) 's Twitter Profile Photo

😮‍💨 took longer to make than anticipated But here are histologic clues for pancreatic cancer > chronic pancreatitis! #pathx #pancreaticcancer #surgoncx #gipath #path #pdac #medstudentx #gi #gastroenterology

😮‍💨 took longer to make than anticipated 

But here are histologic clues for pancreatic cancer > chronic pancreatitis!

#pathx #pancreaticcancer #surgoncx #gipath #path #pdac #medstudentx #gi #gastroenterology
Tim McCalmont (@mccalmo) 's Twitter Profile Photo

Cutaneous blue nevus-like melanoma with BAP1 loss to the far right, precursor cellular blue nevus to the left. One giant step from indolence to potential lethality.

Cutaneous blue nevus-like melanoma with BAP1 loss to the far right, precursor cellular blue nevus to the left. One giant step from indolence to potential lethality.
C. Christofer Juhlin (@drjuhlin) 's Twitter Profile Photo

As much as I love first-generation neuroendocrine markers, one must be aware of pitfalls when assessing lesions with focal/diffuse synaptophysin immunoreactivity. Several non-neuroendocrine tumors may express this marker, so confirmation with additional stains = YES. An example:

Elizabeth Montgomery, MD (@lizmontgomerymd) 's Twitter Profile Photo

Superficial acral fibromyxoma (also termed digital fibromyxoma) was described in 2001. It is benign but prone to recurrences in up to 25% of patients. It is often chock full of mast cells (arrow) and shows consistent CD34 expression. #UMiamiPath PMIDs: 11486169, 22367301.

Superficial acral fibromyxoma (also termed digital fibromyxoma) was described in 2001.  It is benign but prone to recurrences in up to 25% of patients. It is often chock full of mast cells (arrow) and shows consistent CD34 expression.  #UMiamiPath
PMIDs: 11486169,  22367301.
Jerad Gardner, MD (@jmgardnermd) 's Twitter Profile Photo

My 2021 Paris #Dermpath Course (5 hours!) at Institut Curie for IAP France - adnexal tumors, soft tissue, melanocytic, & more. Video: youtube.com/watch?v=5ixiza… #pathology #pathologists #pathTwitter #dermpath #dermatology #dermatologia #dermtwitter

My 2021 Paris #Dermpath Course (5 hours!) at Institut Curie for IAP France - adnexal tumors, soft tissue, melanocytic, & more. 
Video: youtube.com/watch?v=5ixiza…  
#pathology #pathologists #pathTwitter #dermpath #dermatology #dermatologia #dermtwitter
Woo Cheal Cho, MD (@draldehyde) 's Twitter Profile Photo

I always find it fascinating to observe this entity. The prominent epithelioid cells, devoid of BAP1 nuclear expression, stand in stark contrast to the smaller, banal nevus component, which exhibits retained expression. 😆🔬 BAP1-inactivated melanocytoma #dermpath #MDACCPath

I always find it fascinating to observe this entity. The prominent epithelioid cells, devoid of BAP1 nuclear expression, stand in stark contrast to the smaller, banal nevus component, which exhibits retained expression. 😆🔬

BAP1-inactivated melanocytoma

#dermpath #MDACCPath
Silvija Gottesman MD (@sgottesmanmd) 's Twitter Profile Photo

Excellent talk by Dr Susan Taylor, AAD President-elect at Atlantic Derm Conference on central centrifugal cicatricial alopecia. Most salient #dermpath CCCA features 👀🔬below. Peri-isthmic inflammation CD4+ lymphs. In contrast LPP/FFA is (peri-infundibular & CD8+). ⬆️CD1a cells variable

Excellent talk by Dr Susan Taylor, AAD President-elect at <a href="/AtlanticDermADC/">Atlantic Derm Conference</a> on central centrifugal cicatricial alopecia. Most salient #dermpath CCCA features 👀🔬below. Peri-isthmic inflammation CD4+ lymphs. In contrast LPP/FFA is (peri-infundibular &amp; CD8+). ⬆️CD1a cells variable
Steven (@stevenkolkermd) 's Twitter Profile Photo

AFX with keloidal collagen -- a phenomenon that has been reported. The IHC is CD10. To me, block-like (as opposed to heterogenous) positivity for CD10 supports AFX. Pankeratin, CK903, & S100 were negative pubmed.ncbi.nlm.nih.gov/37973539/ pubmed.ncbi.nlm.nih.gov/19476521/ pubmed.ncbi.nlm.nih.gov/37438163/

AFX with keloidal collagen -- a phenomenon that has been reported.  The IHC is CD10.  To me, block-like (as opposed to heterogenous) positivity for CD10 supports AFX.  Pankeratin, CK903, &amp; S100 were negative
pubmed.ncbi.nlm.nih.gov/37973539/
pubmed.ncbi.nlm.nih.gov/19476521/
pubmed.ncbi.nlm.nih.gov/37438163/
Anaísa (Nisa) Quintanilla-Arteaga (@anaisa_qa) 's Twitter Profile Photo

With a new profile pic, it’s time to formally introduce myself, #PathX! My name is Anaísa, and I’ll be applying to #Pathology residency this year #PathMatch25!! Interested in #Hemepath #Cytopath and #4n6 #Forensics Can’t wait to connect with others on their #Path2Path!!🔬

With a new profile pic, it’s time to formally introduce myself, #PathX! My name is Anaísa, and I’ll be applying to #Pathology residency this year #PathMatch25!! Interested in #Hemepath #Cytopath and #4n6 #Forensics Can’t wait to connect with others on their #Path2Path!!🔬